SynthesisFrontiers in public health2026
Effectiveness of pharmaceutical care interventions amid pharmacist role transformation in China: a meta-analysis.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the effectiveness of pharmaceutical care delivered by Chinese pharmacists during their professional role transformation, including prescription review, medication counseling, prescription comment, and the value of pharmacist interventions in multidisciplinary team settings, with the aim of providing evidence-based support for advancing the transformation and optimizing service models of the pharmacy workforce in China. Methods: We searched PubMed, Embase, Cochrane Library, Web of Science, CBM, CNKI, Wanfang, and VIP from inception to April 2026. RCTs and NRSIs examining pharmacist-delivered pharmaceutical care in Chinese institutions were included. Risk of bias was assessed with Cochrane ROB and ROBINS-I. Meta-analyses used odds ratios (ORs) and 95% CIs. Results: Thirty-two studies (5 RCTs, 27 NRSIs) were included. Pharmacist interventions were associated with increased single-agent antimicrobial use (OR 3.13, 95%CI 2.49-3.92) and rational prescriptions (OR 2.97, 95%CI 2.30-3.85), and reduced combination therapy, irrational prescriptions (OR 0.22, 95%CI 0.17-0.28), as well as reduced irrational prescribing in intravenous admixture centers and outpatient settings (non-standard: OR 0.46, 95%CI 0.43-0.49; inappropriate: OR 0.51, 95%CI 0.42-0.62; exceptional: OR 0.26, 95%CI 0.08-0.84). Heterogeneity was substantial ( Conclusion: Pharmacist-led interventions are associated with improved prescribing process indicators in China. However, the evidence is limited by few RCTs, predominance of NRSIs with moderate/high bias, and high heterogeneity. Findings are exploratory and hypothesis-generating. High-quality RCTs with patient-centered outcomes are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.